Mereo BioPharma (MREO) Debt Ratio (2017 - 2020)
Mereo BioPharma (MREO) posted quarterly Debt Ratio of 0.25 for Q2 2020, up 37.3% year-over-year from 0.18 in Q3 2019, and up 6.57% quarter-over-quarter from 0.24 in Q4 2019.
Mereo BioPharma (MREO) Debt Ratio (2017 - 2020) Analysis & Trends
Mereo BioPharma (MREO) has reported Debt Ratio for 4 consecutive years, with 0.25 the latest figure, recorded in Q2 2020.
- In Q2 2020, Debt Ratio rose 37.3% year-over-year to 0.25; the TTM figure through Jun 2020 stood at 0.25 (up 37.3% YoY), while the FY2022 annual figure was 0.17, changed N/A from the prior year.
- Debt Ratio advanced to 0.25 in Q2 2020 per MREO's latest filing, from 0.24 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.32 in Q4 2018 and bottomed at 0.18 in Q2 2019.
- Historically, Debt Ratio has averaged 0.24 across 4 years, with a median of 0.24 in 2019.
- Annual changes were most pronounced in 2018 — Debt Ratio surged 48.25% — and 2019, when it decreased 25.7%.
- Mereo BioPharma's Debt Ratio stood at 0.22 in 2017, then soared by 48.25% to 0.32 in 2018, then retreated by 25.7% to 0.24 in 2019, then rose by 6.57% to 0.25 in 2020.
- Business Quant data shows MREO's Debt Ratio at 0.25 in Q2 2020, 0.24 in Q4 2019, and 0.18 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 0.25 |
| Dec 31, 2019 | 0.24 |
| Jun 30, 2019 | 0.18 |
| Dec 31, 2018 | 0.32 |
| Dec 31, 2017 | 0.22 |